Jane Walker

• Linked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study.

  Wanat M. et al, (2017), BMJ Open, 7

• Screening Medical Patients for Depression: Lessons From a National Program in Cancer Clinics.

  Walker J. et al, (2017), Psychosomatics, 58, 274 - 280

• Patient reaction to the PACE trial - Authors' reply.

  Sharpe M. et al, (2016), Lancet Psychiatry, 3, e8 - e9

• Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.

  Sharpe M. et al, (2015), Lancet Psychiatry, 2, 1067 - 1074

• Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.

  Duarte A. et al, (2015), J Psychosom Res, 79, 465 - 470

• Selecting, training and supervising nurses to treat depression in the medically ill: experience and recommendations from the SMaRT oncology collaborative care trials.

  Wanat M. et al, (2015), Gen Hosp Psychiatry, 37, 518 - 521

• Implementing collaborative care programs for psychiatric disorders in medical settings: a practical guide.

  Beach SR. et al, (2015), Gen Hosp Psychiatry, 37, 522 - 527

• Updates in Psychosomatic Medicine: 2014.

  Freudenreich O. et al, (2015), Psychosomatics, 56, 445 - 459

• Updates in Psychosomatic Medicine: 2014

  Freudenreich O. et al, (2015), Psychosomatics, 56, 445 - 459

• Integrated management of major depression for people with cancer.

  Walker J. and Sharpe M., (2014), Int Rev Psychiatry, 26, 657 - 668

• Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.

  Walker J. et al, (2014), Lancet Psychiatry, 1, 343 - 350

• Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.

  Sharpe M. et al, (2014), Lancet, 384, 1099 - 1108

• Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.

  Walker J. et al, (2014), Lancet Oncol, 15, 1168 - 1176

• Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer.

  Walker S. et al, (2014), Psychol Med, 44, 1451 - 1460

• Treatment of depression in adults with cancer: a systematic review of randomized controlled trials.

  Walker J. et al, (2014), Psychol Med, 44, 897 - 907

• COST-EFFECTIVENESS OF THE SYSTEMATIC IDENTIFICATION AND TREATMENT OF COMORBID MAJOR DEPRESSION FOR PEOPLE WITH CHRONIC DISEASES: THE EXAMPLE OF CANCER

  Walker S. et al, (2013), VALUE IN HEALTH, 16, A414 - A414

• COLLABORATIVE CARE FOR DEPRESSION MANAGEMENT IN CANCER: A COST-EFFECTIVENESS ANALYSIS

  Duarte A. et al, (2013), VALUE IN HEALTH, 16, A412 - A412

• Screening medical patients for distress and depression: does measurement in the clinic prior to the consultation overestimate distress measured at home?

  Hansen CH. et al, (2013), Psychol Med, 43, 2121 - 2128

• Prevalence of depression in adults with cancer: a systematic review.

  Walker J. et al, (2013), Ann Oncol, 24, 895 - 900

• Treatment of depression in people with lung cancer: a systematic review.

  Walker J. et al, (2013), Lung Cancer, 79, 46 - 53

• Sleep problems in cancer patients: prevalence and association with distress and pain.

  Sharma N. et al, (2012), Psychooncology, 21, 1003 - 1009

• Pain in patients attending a specialist cancer service: prevalence and association with emotional distress.

  O'Connor M. et al, (2012), J Pain Symptom Manage, 43, 29 - 38

• Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review.

  Richardson A. et al, (2011), Br J Cancer, 105 Suppl 1, S82 - S94

• Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression.

  Walker J. et al, (2011), Psychosomatics, 52, 424 - 427

• Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.

  Sharpe M. et al, (2011), Neurology, 77, 564 - 572

• What is a psychological intervention? A metareview and practical proposal.

  Hodges LJ. et al, (2011), Psychooncology, 20, 470 - 478

• The problems reported by cancer patients with major depression.

  Kleiboer A. et al, (2011), Psychooncology, 20, 62 - 68

• Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire.

  Thekkumpurath P. et al, (2011), Cancer, 117, 218 - 227

• Recruiting and retaining medical patients in trials of complex interventions: practical experience of challenges and solutions in three multi-centre trials

  Walker J. and Sharpe M., (2011), Trials, 12

• Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.

  Stone J. et al, (2010), Clin Neurol Neurosurg, 112, 747 - 751

• Monitoring symptoms at home: what methods would cancer patients be comfortable using?

  Kleiboer A. et al, (2010), Qual Life Res, 19, 965 - 968

• Measuring improvement in depression in cancer patients: a 50% drop on the self-rated SCL-20 compared with a diagnostic interview.

  O'Connor M. et al, (2010), Gen Hosp Psychiatry, 32, 334 - 336

• Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome.

  Sharpe M. et al, (2010), Psychol Med, 40, 689 - 698

• The HSCL-20: one questionnaire, two versions.

  Walker J. et al, (2010), J Psychosom Res, 68, 313 - 314

• Screening for suicidality in cancer patients using Item 9 of the nine-item patient health questionnaire; does the item score predict who requires further assessment?

  Walker J. et al, (2010), Gen Hosp Psychiatry, 32, 218 - 220

• Patient and general practitioner preferences for the treatment of depression in patients with cancer: how, who, and where?

  Hodges L. et al, (2009), J Psychosom Res, 67, 399 - 402

• Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?

  Stone J. et al, (2009), Brain, 132, 2878 - 2888

• The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (depression care for people with lung cancer) to usual care, compared to usual care alone in patients with lung cancer.

  Walker J. et al, (2009), Trials, 10

• Depression Care for People with Cancer: a collaborative care intervention.

  Walker J. and Sharpe M., (2009), Gen Hosp Psychiatry, 31, 436 - 441

• Symptoms: a new approach

  Sharpe M. and Walker J., (2009), Psychiatry, 8, 146 - 148

• The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients.

  Walker J. et al, (2009), Trials, 10

• Better off dead: suicidal thoughts in cancer patients.

  Walker J. et al, (2008), J Clin Oncol, 26, 4725 - 4730

• Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.

  Strong V. et al, (2008), Lancet, 372, 40 - 48

• Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study.

  Storey DJ. et al, (2007), Ann Oncol, 18, 1861 - 1869

• Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients.

  Walker J. et al, (2007), J Psychosom Res, 63, 83 - 91

• Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study.

  Strong V. et al, (2007), Br J Cancer, 96, 868 - 874

• Commentary: symptoms not associated with disease: an unmet public health challenge.

  Walker J. et al, (2006), Int J Epidemiol, 35, 477 - 478

• Bodily symptoms: new approaches to classification.

  Sharpe M. et al, (2006), J Psychosom Res, 60, 353 - 356

Key Publications

• Treatment of depression in people with lung cancer: a systematic review.

  Walker J. et al, (2013), Lung Cancer, 79, 46 - 53
• Prevalence of depression in adults with cancer: a systematic review.

  Walker J. et al, (2013), Ann Oncol, 24, 895 - 900
• Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.

  Sharpe M. et al, (2011), Neurology, 77, 564 - 572
• Better off dead: suicidal thoughts in cancer patients.

  Walker J. et al, (2008), J Clin Oncol, 26, 4725 - 4730

Recent Publications

• Linked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study.

  Wanat M. et al, (2017), BMJ Open, 7
• Screening Medical Patients for Depression: Lessons From a National Program in Cancer Clinics.

  Walker J. et al, (2017), Psychosomatics, 58, 274 - 280
• Patient reaction to the PACE trial - Authors' reply.

  Sharpe M. et al, (2016), Lancet Psychiatry, 3, e8 - e9
• Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.

  Sharpe M. et al, (2015), Lancet Psychiatry, 2, 1067 - 1074
• Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.

  Duarte A. et al, (2015), J Psychosom Res, 79, 465 - 470